Ropinirole and pramipexole: comparative adverse event profiles Parkinson's disease patients

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 951卷 / 1期
关键词：
Public Health; Adverse Event; Placebo; High Risk; Dopamine;
D O I：
10.2165/00128415-200309510-00013
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [31] An overnight switch to ropinirole therapy in patients with Parkinson's disease
    Canesi, M
    Antonini, A
    Mariani, CB
    Tesei, S
    Zecchinelli, AL
    Barichella, M
    Pezzoli, G
    JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (9-10) : 925 - 929
  • [32] Ropinirole in patients with advanced Parkinson's disease: prospective study
    Relja, M.
    Telarovic, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 116 - 116
  • [33] Switching to ropinirole reduces the severity of daytime sleepiness associated with pramipexole therapy in Parkinson's disease with renal dysfunction
    Baba, Y.
    Higuchi, M. -A.
    Onozawa, R.
    Yamada, T.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S121 - S121
  • [34] A three-arm, open-label conversion study of pramipexole to ropinirole prolonged release tablets in Parkinson's disease patients
    Pahwa, R.
    Lyons, K. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 126 - 127
  • [35] Switching from pergolide to pramipexole in patients with Parkinson's disease
    P. A. Hanna
    L. Ratkos
    W. G. Ondo
    J. Jankovic
    Journal of Neural Transmission, 2001, 108 : 63 - 70
  • [36] Pramipexole Reduces the Prevalence of Fatigue in Patients with Parkinson's Disease
    Morita, Akihiko
    Okuma, Yasuyuki
    Kamei, Satoshi
    Yoshii, Fumihito
    Yamamoto, Toshimasa
    Hashimoto, Shiori
    Utsumi, Hiroya
    Hatano, Taku
    Hattori, Nobutaka
    Matsumura, Miyuki
    Takahashi, Kazushi
    Nogawa, Shigeru
    Watanabe, Yuka
    Miyamoto, Tomoyuki
    Miyamoto, Masayuki
    Hirata, Koichi
    INTERNAL MEDICINE, 2011, 50 (19) : 2163 - 2168
  • [37] Effect of pramipexole on depression and anhedonia in Parkinson's disease patients
    Lemke, MR
    Brecht, M
    Koester, J
    Kraus, PH
    Reichmann, H
    MOVEMENT DISORDERS, 2002, 17 : S224 - S224
  • [38] Switching from pergolide to pramipexole in patients with Parkinson's disease
    Hanna, PA
    Ratkos, L
    Ondo, WG
    Jankovic, J
    JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (01) : 63 - 70
  • [39] Pramipexole marketed for Parkinson's disease
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (17) : 1922 - 1922
  • [40] Pramipexole and Parkinson's disease, an update
    Martinez-Corral, M.
    Kulisevsky, J.
    REVISTA DE NEUROLOGIA, 2008, 46 (01) : 49 - 52
12345